Melanoma, Familial  >>  Mekinist (trametinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mekinist (trametinib) / Novartis, BeiGene
NCT01928940: Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part)

Completed
2
12
Japan
dabrafenib, trametinib
GlaxoSmithKline
Solid Tumours
09/14
07/16
NCT02065063: A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid Tumors

Completed
1/2
28
US
Trametinib, Palbociclib
GlaxoSmithKline, Pfizer
Cancer
06/16
06/16

Download Options